Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Dexamethasone sodium phosphate
Taw Pharma (Ireland) Ltd
H02AB; H02AB02
Dexamethasone sodium phosphate
10 mg/5ml
Oral solution
Glucocorticoids; dexamethasone
Not marketed
2013-12-20
PAGE 1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT IMPORTANT INFORMATION ABOUT THIS MEDICINE • DEXAMETHASONE IS A STEROID MEDICINE, prescribed for many different conditions, including serious illnesses • YOU NEED TO TAKE IT REGULARLY to get the maximum benefit • DON’T STOP TAKING THIS MEDICINE without talking to your doctor – you may need to reduce the dose gradually • DEXAMETHASONE CAN CAUSE SIDE EFFECTS IN SOME PEOPLE (read section 4: Possible side effects). Some problems such as mood changes (feeling depressed or ‘high’) or stomach problems can happen straight away. If you feel unwell, in any way, keep taking your medicine, BUT SEE YOUR DOCTOR STRAIGHT AWAY • SOME SIDE EFFECTS ONLY HAPPEN AFTER WEEKS OR MONTHS. These include weakness of arms and legs or developing a rounder face (read section 4 for more information) • KEEP AWAY FROM PEOPLE WHO HAVE CHICKEN-POX, SHINGLES OR MEASLES, if you have never had them. They could affect you severely. If you do come into contact with anyone, SEE YOUR DOCTOR STRAIGHT AWAY. NOW READ THE REST OF THIS LEAFLET. It includes other important information on the safe and effective use of this medicine that might be especially important for you. THIS LEAFLET WAS LAST UPDATED ON 12/2022. • Read all of this leaflet carefully before you start taking this medicine. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET 1. What Dexamethasone Oral Solution is and what it is used for 2. What you need to know before you take Dexamethasone Oral Solution 3. How to take Dexamethasone Oral Solution 4. Possible side effects 5. How to store Dexamethasone Oral Solution 6. Contents of the pack and ot Read the complete document
Health Products Regulatory Authority 26 January 2023 CRN00D9JL Page 1 of 15 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dexamethasone 10mg/5ml Oral Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5ml contains 10mg Dexamethasone (as dexamethasone sodium phosphate) 1ml contains 2mg Dexamethasone (as dexamethasone sodium phosphate) Excipients with known effect: Liquid maltitol (E965) - 1375mg/5ml (275mg/ml) Sorbitol (E420) liquid (non crystallising) -700mg/5ml (140mg/ml) Propylene Glycol (E1520) – 450mg/5ml Benzoic acid (E210) – 5mg/5ml For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oral Solution A colourless to faint yellow solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dexamethasone is a corticosteroid. It is designed for use in certain endocrine and non-endocrine disorders, in certain cases of cerebral oedema and for diagnostic testing of adrenocortical hyperfunction. Endocrine disorders: Endocrine exophthalmos. Non-endocrine disorders: Dexamethasone may be used in the treatment of non-endocrine corticosteroid responsive conditions including: Allergy and anaphylaxis: Anaphylaxis. Arteritis collagenosis: Polymyalgia rheumatica, polyarteritis nodosa. Haematological disorders: Haemolytic anaemia (also auto immune), leukaemia, myeloma, idiopathic thrombocytopenic purpura in adults, reticulolymphoproliferative disorders (see also under oncological disorders). Gastroenterological disorders: For treatment during the critical stage in: ulcerative colitis (rectal only); regional enteritis (Crohn's disease), certain forms of hepatitis. Muscular disorders: Polymyositis. Neurological disorders: Raised intra-cranial pressure secondary to cerebral tumours, acute exacerbations of multiple sclerosis. Ocular disorders: Anterior and posterior uveitis, optic neuritis, chorioretinitis, iridocyclitis, temporal arteritis, orbital pseudotumour. Renal disorders: Nephrotic syndrome Health Products Regulatory Authority 26 January 2023 CRN00D9JL Page 2 of 15 Pulmonary Read the complete document